Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label, Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CUD005 Injection in Patients with Liver Cirrhosis

NCT06671275 is registered in ClinicalTrials.gov with Anhui Provincial Hospital as lead sponsor.

NCT NCT06671275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06671275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label, Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CUD005 Injection in Patients with Liver Cirrhosis
Lead sponsor
Anhui Provincial Hospital
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
June 21, 2024
Completion date
July 31, 2026
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis liver